Closed abdomen hyperthermic intraperitoneal chemotherapy with irinotecan and mitomycin C: a phase I study (Q33394590)

26 July 2017

title

Closed abdomen hyperthermic intraperitoneal chemotherapy with irinotecan and mitomycin C: a phase I study (English)

1 reference

26 July 2017

1 reference

Olivier Glehen

8

0 references

author name string

Eddy Cotte

1

1 reference

26 July 2017

Guillaume Passot

2

1 reference

26 July 2017

Michel Tod

3

1 reference

26 July 2017

Naoual Bakrin

4

1 reference

26 July 2017

François-Noël Gilly

5

1 reference

26 July 2017

Aline Steghens

6

1 reference

26 July 2017

Faheez Mohamed

7

1 reference

26 July 2017

publication date

19 March 2011

1 reference

Annals of Surgical Oncology

26 July 2017

published in

1 reference

26 July 2017

volume

18

1 reference

26 July 2017

issue

9

1 reference

26 July 2017

page(s)

2599-2603

1 reference

26 July 2017

cites work

Peritonectomy procedures

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1651-1

Hyperthermic intraperitoneal chemotherapy: nomenclature and modalities of perfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1651-1

New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1651-1

Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1651-1

8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1651-1

A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1651-1

Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: a single western center experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1651-1

Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1651-1

Heated intra-operative intraperitoneal oxaliplatin alone and in combination with intraperitoneal irinotecan: Pharmacologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1651-1

Which method to deliver hyperthermic intraperitoneal chemotherapy with oxaliplatin? An experimental comparison of open and closed techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1651-1

Management of peritoneal carcinomatosis from colorectal cancer: current state of practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1651-1

Phase I study of intraperitoneal irinotecan in patients with gastric adenocarcinoma with peritoneal seeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1651-1

10.1245/S10434-011-1651-1

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

26 July 2017

1030378264

0 references

1 reference